CYP.AX · CYNATA THERAPEUTICS LIMITED
Australia · RS rating 18 · As of 2026-10-14
| Price | 0.01 AUD |
|---|---|
| 1-day change | -15.4% |
| RS rating (overall / 1M / 3M / 12M) | 18 / 67 / 41 / 1 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 24 / 18 / 3 |
| Industry group (rank) | Medical-Biomed/Biotech (–) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | – |
| Distance from 52-week high | +97.2% |
| Market cap (USD) | $2.4M |